KR101088740B1 - 샤페로닌 10을 이용한 면역억제 방법 - Google Patents

샤페로닌 10을 이용한 면역억제 방법 Download PDF

Info

Publication number
KR101088740B1
KR101088740B1 KR1020057008096A KR20057008096A KR101088740B1 KR 101088740 B1 KR101088740 B1 KR 101088740B1 KR 1020057008096 A KR1020057008096 A KR 1020057008096A KR 20057008096 A KR20057008096 A KR 20057008096A KR 101088740 B1 KR101088740 B1 KR 101088740B1
Authority
KR
South Korea
Prior art keywords
cpn10
delete delete
gvhd
cells
transplantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020057008096A
Other languages
English (en)
Korean (ko)
Other versions
KR20050086428A (ko
Inventor
제프리 알. 힐
타트자나 바노빅
할레 모튼
앨리스 크리스티나 카바나그
Original Assignee
씨바이오 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨바이오 리미티드 filed Critical 씨바이오 리미티드
Publication of KR20050086428A publication Critical patent/KR20050086428A/ko
Application granted granted Critical
Publication of KR101088740B1 publication Critical patent/KR101088740B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020057008096A 2002-11-06 2003-11-06 샤페로닌 10을 이용한 면역억제 방법 Expired - Fee Related KR101088740B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
AU2002952492 2002-11-06
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (2)

Publication Number Publication Date
KR20050086428A KR20050086428A (ko) 2005-08-30
KR101088740B1 true KR101088740B1 (ko) 2011-12-01

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057008096A Expired - Fee Related KR101088740B1 (ko) 2002-11-06 2003-11-06 샤페로닌 10을 이용한 면역억제 방법

Country Status (16)

Country Link
US (3) US7618935B2 (enExample)
EP (3) EP2818179A1 (enExample)
JP (2) JP4716731B2 (enExample)
KR (1) KR101088740B1 (enExample)
CN (1) CN100525832C (enExample)
AT (1) ATE489963T1 (enExample)
AU (1) AU2002952492A0 (enExample)
CA (1) CA2505141C (enExample)
CY (1) CY1110972T1 (enExample)
DE (1) DE60335202D1 (enExample)
DK (1) DK1569679T3 (enExample)
ES (1) ES2351993T3 (enExample)
NZ (1) NZ540433A (enExample)
PT (1) PT1569679E (enExample)
SI (1) SI1569679T1 (enExample)
WO (1) WO2004041300A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067959A1 (en) * 2004-01-16 2005-07-28 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
BRPI0613515A2 (pt) * 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
BRPI0615284A2 (pt) 2005-08-31 2011-05-17 Cbio Ltd chaperonina 10 modificada
EP1951282A4 (en) * 2005-10-20 2009-09-02 Cbio Ltd TREATMENT OF HYPERSENSITIVITY
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CN101443032A (zh) 2006-03-02 2009-05-27 悉生物有限公司 通过调节抗原呈递细胞的功能调节免疫反应
NZ588467A (en) * 2008-04-11 2012-11-30 Cbio Ltd Modified chaperonin 10 (CPN10) polypeptides and pattern recognition receptor (PRR) signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
KR102239867B1 (ko) 2012-12-10 2021-04-13 앨러간 파마슈티컬스 인터내셔널 리미티드 확장 가능한 3-차원 탄성 구조물 제조
KR102488446B1 (ko) 2013-08-13 2023-01-13 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
ATE282634T1 (de) * 1993-11-30 2004-12-15 Univ Queensland Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
JPH11510806A (ja) * 1995-08-09 1999-09-21 シェーリング コーポレイション 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
AU7361900A (en) * 1999-09-10 2001-04-10 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
CA2505141A1 (en) 2004-05-21
US20120082690A1 (en) 2012-04-05
DE60335202D1 (en) 2011-01-13
EP1569679B1 (en) 2010-12-01
EP1569679A1 (en) 2005-09-07
EP2255824A1 (en) 2010-12-01
NZ540433A (en) 2008-03-28
CA2505141C (en) 2012-07-17
ES2351993T3 (es) 2011-02-14
EP2818179A1 (en) 2014-12-31
JP2006508099A (ja) 2006-03-09
CN1735428A (zh) 2006-02-15
PT1569679E (pt) 2010-12-14
DK1569679T3 (da) 2011-01-10
EP1569679A4 (en) 2008-02-27
JP4716731B2 (ja) 2011-07-06
US20060198834A1 (en) 2006-09-07
US20100099605A1 (en) 2010-04-22
CN100525832C (zh) 2009-08-12
US8067361B2 (en) 2011-11-29
SI1569679T1 (sl) 2011-01-31
CY1110972T1 (el) 2015-06-11
AU2002952492A0 (en) 2002-11-21
US7618935B2 (en) 2009-11-17
EP2255824B1 (en) 2014-07-23
ATE489963T1 (de) 2010-12-15
WO2004041300A1 (en) 2004-05-21
JP2011088920A (ja) 2011-05-06
KR20050086428A (ko) 2005-08-30

Similar Documents

Publication Publication Date Title
US8067361B2 (en) Chaperonin 10 immunosuppression
US6197302B1 (en) Method of stimulating T cells
US6203795B1 (en) Pharmaceutical composition for the treatment or prevention of a malignant tumor
JP3798426B2 (ja) 自己免疫疾患の治療におけるｉｌ−１２およびｉｌ−１２アンタゴニストの使用
DE69520088T3 (de) Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten
JP2018524299A (ja) 免疫応答を調節するための方法およびポリペプチド
US6441138B2 (en) Protein which induces interferon-γ production by immunocompetent cell
JP2000516570A (ja) アレルギー反応の標的治療のためのＦｃε―ＰＥキメラタンパク質、その製造方法、及びそれを含む薬剤組成物
WO1992006117A1 (en) Inhibiting unwanted immune responses
KR20000075749A (ko) 신규의 폴리펩티드, 그 폴리펩티드를 암호하는 ｄｎａ 및 그용도
JPH10505839A (ja) グラム陽性細菌及びマイコバクテリアの作用を阻止するための抗体の使用
KR100692226B1 (ko) 신규 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및 그 용도
WO1996011700A1 (en) Reduction of mammalian neoplasms with phospholipase a2 activatiing substances
WO2000008056A1 (fr) NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION
AU2003277992B2 (en) Chaperonin 10 immunosuppression
JP4026923B2 (ja) ポリペプチド
AU2562300A (en) Adjuvant and cell maturation agent
AU783851B2 (en) Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
NZ299943A (en) Protein stimulator of ifn-gamma in immunocompetant cells

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20141124

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20151125

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20161126

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20161126